Search

Quanterix Corp

Slēgts

SektorsVeselības aprūpe

2.91 6.99

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.67

Max

2.95

Galvenie mērījumi

By Trading Economics

Ienākumi

-31M

-49M

Pārdošana

-3.5M

33M

EPS

-0.45

Peļņas marža

-148.708

Darbinieki

450

EBITDA

-38M

-49M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+10.29% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 9. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

4.2M

118M

Iepriekšējā atvēršanas cena

-4.08

Iepriekšējā slēgšanas cena

2.91

Ziņu noskaņojums

By Acuity

50%

50%

129 / 339 Rangs Healthcare

Quanterix Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 15. sept. 20:01 UTC

Quanterix Corp shares are higher during Tuesday's session, maintaining positive momentum despite a broader market decline tied to the NY Empire State Manufacturing Index.

2026. g. 14. sept. 20:03 UTC

News

Quanterix Corp appointed Dr. Yuri Fesko as Chief Medical Officer, yet shares are trading lower amid ongoing performance weakness.

2026. g. 11. sept. 19:26 UTC

Quanterix Corp shares are higher amid market response to steady inflation data. Earlier, the stock pulled back from a session high before regaining momentum.

2026. g. 10. sept. 20:07 UTC

Quanterix Corp shares are lower today, pressured by broader market conditions following the European Central Bank's interest rate hike.

2026. g. 9. sept. 20:07 UTC

Quanterix Corp shares are lower today, reaching a session low amid ongoing weakness and trading near the lower end of their one-month range.

2026. g. 8. sept. 20:07 UTC

Quanterix Corp shares are higher today, reflecting broader market dynamics amid speculation over a potential Federal Reserve interest rate hike.

2026. g. 4. sept. 20:08 UTC

Quanterix Corp shares are higher today, continuing a strong upward trend since Thursday's close, despite broader market pressures from a strong jobs report.

2026. g. 3. sept. 20:07 UTC

Quanterix Corp shares are lower today, continuing a decline since Wednesday. The stock is near the lower end of its one-month range.

2026. g. 2. sept. 19:46 UTC

Quanterix Corp shares are higher today, though still below their 20-day moving average. Broader market conditions are affected by rising U.S. Treasury yields.

2026. g. 1. sept. 20:01 UTC

Quanterix Corp shares are lower today, continuing a decline since Monday. Broader market concerns include rising oil prices and inflation expectations.

2026. g. 31. aug. 19:16 UTC

Quanterix Corp shares are lower amid market anxiety following hawkish remarks from Federal Reserve Chair Kevin Warsh on potential interest rate hikes.

2026. g. 28. aug. 23:41 UTC

Quanterix Corp shares are lower in after-market trading, following a decline earlier in the session amid rising U.S. Treasury yields and falling tech stocks.

2026. g. 24. aug. 20:02 UTC

Quanterix Corp shares are lower today, continuing a decline that began Friday. The stock is near the lower end of its one-month range.

2026. g. 22. aug. 00:02 UTC

Quanterix Corp shares are lower in after-market trading, continuing a decline since Friday's close, with no specific news identified for the movement.

2026. g. 20. aug. 20:06 UTC

Quanterix Corp shares are higher today amid increased market activity. The stock's movement aligns with broader trends, including rising U.S. Treasury yields and crude oil prices.

2026. g. 19. aug. 22:31 UTC

Quanterix Corp shares are higher in after-market trading, reflecting a broader equity rebound after the Treasury's announcement of increased buyback operations for longer-term debt.

2026. g. 18. aug. 23:06 UTC

Quanterix Corp. shares are roughly flat in after-market hours. The stock remains near the lower end of its one-month range.

2026. g. 17. aug. 20:01 UTC

News

Quanterix Corp shares are higher after Director William P. Donnelly's insider purchase of 72,245 shares at $2.93, despite a price target cut by Canaccord Genuity.

2026. g. 14. aug. 23:01 UTC

Quanterix Corp shares are higher in after-market trading, despite no specific news. This follows mixed market sentiment after a decline in U.S. retail sales.

2026. g. 13. aug. 20:02 UTC

Quanterix Corp shares are lower today amid a broader decline in the Life Sciences Tools & Services sub-sector, continuing a downward trend since Wednesday.

2026. g. 12. aug. 23:01 UTC

Quanterix Corp. shares are trading roughly flat in after-market hours. The stock has seen a significant decline over the past month, remaining below its 20-day moving average.

2026. g. 11. aug. 22:51 UTC

Quanterix Corp shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressure and rising crude oil prices.

2026. g. 10. aug. 19:51 UTC

Event
Social Media
News

Quanterix Corp reported a wider second-quarter loss and lowered full-year revenue guidance, leading to a significant decline in shares amid investor concerns.

2026. g. 7. aug. 19:16 UTC

Quanterix Corp shares are higher today, continuing a trend with three consecutive sessions of gains since Thursday. The stock is trading above its 20-day moving average.

2026. g. 5. aug. 19:23 UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

2026. g. 3. aug. 19:26 UTC

Quanterix Corp shares are higher today, tracking broader market gains amid rising confidence in tech stocks and falling energy prices.

2026. g. 31. jūl. 19:46 UTC

Quanterix Corp shares are higher today, reflecting a modest gain since Thursday's close. The stock is near the lower end of its one-month range.

2026. g. 30. jūl. 19:59 UTC

Quanterix Corp is trading higher amid a broader recovery in tech shares. The asset has shown notable volatility, pulling back from earlier session highs.

2026. g. 29. jūl. 19:43 UTC

Macro Event

Quanterix Corp's shares are lower today amid broader market declines, reflecting heightened volatility following the Federal Reserve's decision to maintain interest rates.

2026. g. 28. jūl. 20:06 UTC

Quanterix Corp shares are declining amid broader market weakness, with the Nikkei 225 dropping significantly due to concerns over AI spending and semiconductor competition.

Salīdzinājums

Cenas izmaiņa

Quanterix Corp Prognoze

Cenas mērķis

By TipRanks

10.29% augšup

Prognoze 12 mēnešiem

Vidējais 3 USD  10.29%

Augstākais 3 USD

Zemākais 3 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Quanterix Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

2 ratings

0

Pirkt

2

Turēt

0

Pārdot

Noskaņojums

By Acuity

129 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat